Unsedated Esophagogastroduodenoscopy Unsedated Esophagogastroduodenoscopy, Lidocaine Spray, Anti-inflammatory Throat spray
Conditions
Interventions
A placebo spray of normal saline, followed by two puffs of lidocaine spray on the left, right, and center of the oropharynx using a tongue depressor,An anti-inflammatory throat spray, followed by two
Placebo Comparator Drug,Active Comparator Drug
Lidocaine Spray ,Lidocaine Spray combination with Anti-inflammatory Throat spray
Sponsors
Arunluk Buranathawornsom
Eligibility
Sex/Gender
All
Age
15 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1.Patients aged 15 years and older. 2.Patients undergoing upper gastrointestinal endoscopy at Yala Regional Hospital. 3.Indications for diagnostic endoscopy include cancer screening and evaluation of symptoms such as dysphagia, indigestion, gastroesophageal reflux, abdominal pain, or anemia. 4.Patients undergoing endoscopy must not receive intravenous sedation. 5.Patients must consent to participate in the research study
Exclusion criteria
Exclusion criteria: (1) Head and neck cancer patients (2) Previous surgery of the upper aerodigestive tract (3) corrosive ingestion (4) Pregnant (5) Contraindications for EGD (6) Allergy to medications, lidocaine, or NSAID (7) Psychiatric problem, neuromuscular disorder (8) Emergency conditions or with unstable vital signs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the patient satisfaction, pain, and discomfort 6 to 12 months STATA MP 18 | — |
Secondary
| Measure | Time frame |
|---|---|
| endoscopist's satisfaction, the endoscopist's perception of the patient's tolerance, ease of endoscope insertion, procedure duration, successful endoscopy, and adverse events. 6 to 12 months STATA MP 18 | — |
Countries
Thailand
Contacts
Public ContactArunluk Buranathawornsom
Yala hospital
Outcome results
None listed